title: Findings of a U.S. national cardiometabolic screening program among 10,084 psychiatric outpatients.
abstract: OBJECTIVE
  A national cardiometabolic screening program for patients in a variety of public mental health facilities, group practices, and community behavioral health clinics was funded by Pfizer Inc. between 2005 and 2008.
  
  
  METHODS
  A one-day, voluntary metabolic health fair in the United States offered patients attending public mental health clinics free cardiometabolic screening and same-day feedback to physicians from a biometrics testing third party that was compliant with the Health Insurance Portability and Accountability Act.
  
  
  RESULTS
  This analysis included 10,084 patients at 219 sites; 2,739 patients (27%) reported having fasted for over eight hours. Schizophrenia or bipolar disorder was self-reported by 6,233 (62%) study participants. In the overall sample, the mean waist circumference was 41.1 inches for men and 40.4 inches for women; 27% were overweight (body mass index [BMI] 25.0-29.9 kg/m(2)), 52% were obese (BMI >or=30.0 kg/m(2)), 51% had elevated triglycerides (>or=150 mg/dl), and 51% were hypertensive (>or=130/85 mm Hg). In the fasting sample, 52% had metabolic syndrome, 35% had elevated total cholesterol (>or=200 mg/dl), 59% had low levels of high-density lipoprotein cholesterol (<40 mg/dl for men or <50 mg/dl for women), 45% had elevated triglycerides (>or=150 mg/dl), and 33% had elevated fasting glucose (>or=100 mg/dl). Among the 1,359 fasting patients with metabolic syndrome, 60% were not receiving any treatment. Among fasting patients who reported treatment for specific metabolic syndrome components, 33%, 65%, 71%, and 69% continued to have elevated total cholesterol, low levels of high-density lipoprotein, high blood pressure, and elevated glucose levels, respectively.
  
  
  CONCLUSIONS
  The prevalence of metabolic syndrome and cardiometabolic risk factors, such as overweight, hypertension, dyslipidemia, and glucose abnormalities, was substantial and frequently untreated in this U.S. national mental health clinic screening program.
authors.affiliation: Psychiatry Research Division, Zucker Hillside Hospital, Long Island Jewish Medical Center, Glen Oaks, NY 11004, USA. ccorrell@lij.edu
authors.forename: Christoph U
authors.initials: CU
authors.lastname: Correll
authors.forename: Benjamin G
authors.initials: BG
authors.lastname: Druss
authors.forename: Ilise
authors.initials: I
authors.lastname: Lombardo
authors.forename: Cedric
authors.initials: C
authors.lastname: O'Gorman
authors.forename: James P
authors.initials: JP
authors.lastname: Harnett
authors.forename: Kafi N
authors.initials: KN
authors.lastname: Sanders
authors.forename: Jose M
authors.initials: JM
authors.lastname: Alvir
authors.forename: Brian J
authors.initials: BJ
authors.lastname: Cuffel
mesh_terms: D000293:Adolescent; D000328:Adult; D002318:Cardiovascular Diseases / Q000175:diagnosis* / Q000453:epidemiology; D005260:Female; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000458:organization & administration*; D001523:Mental Disorders; D024821:Metabolic Syndrome / Q000453:epidemiology; D008875:Middle Aged; D010808:Physical Examination; D012307:Risk Factors; D014481:United States / Q000453:epidemiology; D055815:Young Adult